Monograph No. 004 / Vitamins
Vitamins
Vitamin E: Benefits, Dosage, and Safety
Vitamin E is a fat-soluble antioxidant vitamin; the adult RDA is 15 mg per day of alpha-tocopherol, with a Tolerable Upper Intake Level of 1,000 mg per day for adults.
Vitamin E is a fat-soluble antioxidant vitamin; the adult RDA is 15 mg per day of alpha-tocopherol, with a Tolerable Upper Intake Level of 1,000 mg per day for adults.
What vitamin e is
Vitamin E is the collective name for a group of eight fat-soluble compounds (alpha-, beta-, gamma-, and delta-tocopherol and the corresponding four tocotrienols) with antioxidant activity. Alpha-tocopherol is the only form recognized to meet human requirements and the only one the liver preferentially maintains in plasma via the hepatic alpha-tocopherol transfer protein. Naturally sourced vitamin E is RRR-alpha-tocopherol (labeled d-alpha-tocopherol); the synthetic form is all-rac-alpha-tocopherol (labeled dl-alpha-tocopherol) and is about half as biologically active by weight.
What it does
- Acts as a fat-soluble antioxidant that stops the production of reactive oxygen species formed when fat undergoes oxidation, protecting cells from free-radical damage (per ODS)
- Contributes to normal immune function (per ODS)
- Involved in cell signaling, regulation of gene expression, and other metabolic processes, shown primarily in in vitro cell studies (per ODS)
- Alpha-tocopherol inhibits protein kinase C activity, an enzyme involved in cell proliferation and differentiation in smooth muscle cells, platelets, and monocytes (per ODS)
- Supports endothelial cells lining blood vessels and increases release of prostacyclin, which dilates blood vessels and inhibits platelet aggregation (per ODS)
How much vitamin e per day
These are population reference values from the NIH and the Dietary Reference Intakes. They are targets for healthy people, not personal prescriptions. The last column is the Tolerable Upper Intake Level, the most you should get from all sources combined.
| Life stage | Daily target | Type | Upper limit |
|---|---|---|---|
| Infants 0-6 months | 4 mg (6 IU natural / 8.9 IU synthetic) | AI | not established |
| Infants 7-12 months | 5 mg (7.5 IU natural / 11.1 IU synthetic) | AI | not established |
| Children 1-3 years | 6 mg (8.9 IU natural / 13.3 IU synthetic) | RDA | 200 mg |
| Children 4-8 years | 7 mg (10.4 IU natural / 15.5 IU synthetic) | RDA | 300 mg |
| Children 9-13 years | 11 mg (16.4 IU natural / 24.4 IU synthetic) | RDA | 600 mg |
| Adolescents 14-18 years | 15 mg (22.4 IU natural / 33.3 IU synthetic) | RDA | 800 mg |
| Adults 19+ years | 15 mg (22.4 IU natural / 33.3 IU synthetic) | RDA | 1,000 mg |
| Pregnancy (14-18 years) | 15 mg | RDA | 800 mg |
| Pregnancy (19+ years) | 15 mg | RDA | 1,000 mg |
| Lactation (14-18 years) | 19 mg | RDA | 800 mg |
| Lactation (19+ years) | 19 mg | RDA | 1,000 mg |
More is not better: staying near the target covers almost everyone, and routinely exceeding the upper limit can be harmful.
Deficiency and who is at risk
Frank vitamin E deficiency is rare, and overt deficiency symptoms have not been found in otherwise healthy people who get little vitamin E from their diets. When deficiency does occur, usually secondary to fat-malabsorption disorders or rare genetic conditions, signs include peripheral neuropathy, ataxia, skeletal myopathy, retinopathy, and impairment of the immune response. Severe deficiency from abetalipoproteinemia or ataxia with vitamin E deficiency (AVED) can cause nerve damage, muscle weakness, retinal degeneration leading to blindness, and loss of the ability to walk.
Groups more likely to fall short
- People with fat-malabsorption disorders (for example Crohn's disease or cystic fibrosis) or an inability to secrete bile into the digestive tract
- Premature, very low birth weight infants (under 1,500 grams)
- People with abetalipoproteinemia (rare inherited fat-malabsorption disorder)
- People with ataxia and vitamin E deficiency (AVED), a rare inherited defect of the alpha-tocopherol transfer protein
Who may need more
- People with fat-malabsorption disorders such as Crohn's disease, cystic fibrosis, or cholestatic liver disease who cannot absorb dietary fat and may require water-soluble forms
- People with the rare inherited disorders abetalipoproteinemia or AVED, who need large supervised doses
- Premature very low birth weight infants, under medical supervision
- Most healthy people meet needs through diet; national surveys show many Americans consume less than the RDA from food, though frank deficiency is still rare
Food sources
Nuts, seeds, and vegetable oils are the richest sources of alpha-tocopherol; green leafy vegetables and fortified cereals also contribute. Examples per serving: wheat germ oil 1 tablespoon (20.3 mg), sunflower seeds dry roasted 1 ounce (7.4 mg), dry roasted almonds 1 ounce (6.8 mg), sunflower oil 1 tablespoon (5.6 mg), safflower oil 1 tablespoon (4.6 mg), hazelnuts 1 ounce (4.3 mg), peanut butter 2 tablespoons (2.9 mg), corn oil 1 tablespoon (1.9 mg), boiled spinach half cup (1.9 mg), boiled broccoli half cup (1.2 mg).
Forms and absorption
Supplements typically provide only alpha-tocopherol, though mixed products with other tocopherols and tocotrienols exist. Natural (RRR-alpha-tocopherol; d- or D-labeled) exists as one stereoisomer and is about twice as biologically active by weight as synthetic (all-rac-alpha-tocopherol; dl- or DL-labeled), which contains equal amounts of eight stereoisomers, only four of which are retained by the body. Alpha-tocopherol is often esterified (alpha-tocopheryl acetate or succinate) to extend shelf life; the body hydrolyzes and absorbs these esters as efficiently as free alpha-tocopherol. Most vitamin-E-only supplements provide 67 mg or more (100 IU or more of natural vitamin E), well above the RDA. Water-soluble tocopheryl polyethylene glycol-1000 succinate is used for people with malabsorption.
Safety, excess and interactions
Vitamin E from food is considered safe with no established adverse effects. Supplemental alpha-tocopherol has a Tolerable Upper Intake Level of 1,000 mg per day for adults (equivalent to 1,500 IU per day of the natural form or 1,100 IU per day of the synthetic form), which applies to all forms of supplemental alpha-tocopherol. The UL is based on the risk of hemorrhage. Long-term intakes above the UL raise the risk of adverse health effects, and high doses may increase risk of hemorrhagic stroke and, in men, prostate cancer. People on blood thinners or scheduled for surgery, and those undergoing cancer chemotherapy or radiotherapy, should discuss vitamin E use with a health care provider.
Too much
Research has not found adverse effects from vitamin E obtained from food. High-dose alpha-tocopherol supplements can cause hemorrhage and interrupt blood coagulation because they inhibit platelet aggregation and antagonize vitamin K-dependent clotting factors. Two clinical trials found an increased risk of hemorrhagic stroke among people taking alpha-tocopherol (one in Finnish male smokers taking 50 mg per day for about 6 years, and one in US male physicians taking 400 IU synthetic vitamin E every other day for 8 years). Two meta-analyses linked high-dose supplementation to small but statistically significant increases in all-cause mortality, with risk beginning to rise around 150 IU per day in one analysis, though the implications remain unclear and disputed. The SELECT trial found that 400 IU per day of synthetic vitamin E (180 mg) was associated with a statistically significant 17 percent increased risk of prostate cancer in healthy men.
Interactions to know
- Anticoagulant and antiplatelet medications (for example warfarin/Coumadin): vitamin E can inhibit platelet aggregation and antagonize vitamin K-dependent clotting factors, so large doses can increase bleeding risk, especially with low vitamin K intake; the amount needed for a clinically significant effect is unknown but probably exceeds 400 IU per day (per ODS)
- Simvastatin (Zocor) plus niacin: vitamin E taken with other antioxidants (vitamin C, selenium, beta-carotene) blunted the rise in HDL cholesterol, especially the cardioprotective HDL2 fraction, in people treated with the simvastatin-niacin combination (per ODS)
- Chemotherapy and radiotherapy: oncologists generally advise against antioxidant supplements during cancer treatment because they might reduce effectiveness by protecting cancer cells from oxidative damage, though evidence is mixed and further research is needed (per ODS)
How status is measured
Status is measured by serum or plasma alpha-tocopherol concentration, the only form maintained in plasma. ODS notes a primary limitation is the lack of validated biomarkers linking intake and status to clinical outcomes; the FNB has called for research to identify better biomarkers of vitamin E requirements.
What the evidence supports
We grade the strength of evidence behind each common reason people take vitamin e, mirroring how the NIH describes it.
ODS describes alpha-tocopherol's antioxidant role and involvement in immune function as established; it is the recognized essential form with a defined RDA.
ODS documents that deficiency causes peripheral neuropathy, ataxia, myopathy, and retinopathy, and that supplementation is required in these conditions.
ODS: in general, clinical trials (HOPE, HOPE-TOO, Women's Health Study, Physicians' Health Study II) have not provided evidence that routine supplements prevent cardiovascular disease; some data suggest increased heart failure and hemorrhagic stroke risk.
ODS: evidence to date is insufficient to support taking vitamin E to prevent cancer; large-dose supplements (400 IU synthetic) may increase the risk of prostate cancer (SELECT trial).
ODS: available evidence is inconsistent; vitamin E alone has not shown benefit, though the multi-nutrient AREDS/AREDS2 formulations (with vitamin E, zinc, copper, and other antioxidants) show promise for slowing progression of advanced AMD in high-risk people.
ODS: most research does not support use by healthy or mildly impaired people; trials are mixed and more research is needed.
Sources
- S1.gov verifiedNIH Office of Dietary SupplementsVitamin E - Health Professional Fact Sheetods.od.nih.gov/factsheets/VitaminE-HealthProfessiona
- S2.gov verifiedNIH Office of Dietary SupplementsVitamin E - Consumer Fact Sheetods.od.nih.gov/factsheets/VitaminE-Consumer/
- S3.gov verifiedInstitute of Medicine (National Academies), Food and Nutrition BoardDietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids (2000)nap.nationalacademies.org/catalog/9810/dietary-refer
Every figure on this page is quoted from the sources above. Science changes; we re-check and re-date pages as authorities update their guidance.